Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11696991 | PMC |
| http://dx.doi.org/10.1101/cshperspect.a041815 | DOI Listing |
Publication Analysis
Top Keywords
corrigendum preclinical
4
preclinical modeling
4
modeling pathway-targeted
4
pathway-targeted therapy
4
therapy human
4
human lung
4
lung cancer
4
cancer mouse
4
corrigendum
1
modeling
1
Similar Publications
Corrigendum: The immunomodulatory impact of naturally derived neem leaf glycoprotein on the initiation progression model of 4NQO induced murine oral carcinogenesis: a preclinical study.
Front Immunol
November 2024
Department of Immunoregulation and Immunodiagnostics, Chittaranjan National Cancer Institute, Kolkata, India.
[This corrects the article DOI: 10.3389/fimmu.2024.
View Article and Find Full Text PDFCorrigendum: A disintegrin and metalloproteinase domain 10 expression inhibition by the small molecules adenosine, cordycepin and N6, N6-dimethyladenosine and immune regulation in malignant cancers.
Front Immunol
November 2024
Key Laboratory of Epigenetics and Oncology, The Research Center for Preclinical Medicine, Southwest Medical University, Luzhou, Sichuan, China.
[This corrects the article DOI: 10.3389/fimmu.2024.
View Article and Find Full Text PDFCorrigendum to "Regulation of extracellular matrix degradation and metastatic spread by IQGAP1 through endothelin-1 receptor signalling in ovarian cancer" [Matrix Biol. 81 (2019) 17-33].
Matrix Biol
February 2025
Unit of Preclinical Models and New Therapeutic Agents, IRCCS - Regina Elena National Cancer Institute, Rome, Italy. Electronic address:
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!